ICD-10 Code C86.60 | Primary cutaneous CD30-positive T-cell prolif not remission Symptoms, Diagnosis, Billing

Primary cutaneous CD30-positive T-cell proliferation not in remission is a type of skin lymphoma characterized by the proliferation of CD30-positive T-cells. This condition is clinically significant as it can lead to skin lesions and systemic symptoms. Accurate coding with ICD-10 Code C86.60 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.

What is ICD-10 Code C86.60 for Primary cutaneous CD30-positive T-cell prolif not remission?

ICD-10 Code C86.60 represents Primary cutaneous CD30-positive T-cell proliferation not in remission, a condition where malignant T-cells are present in the skin. This code is used when the disease is active and not in remission, indicating the need for ongoing treatment and monitoring. It is crucial for clinical documentation and billing to ensure appropriate care and resource allocation.

ICD-10 Code C86.60 – Clinical Definition and Explanation of Primary cutaneous CD30-positive T-cell prolif not remission

Primary cutaneous CD30-positive T-cell proliferation not in remission is caused by the abnormal growth of T-cells in the skin, often presenting as nodules or plaques. This condition requires medical attention due to its potential to progress and cause significant morbidity.

Key Clinical Features:

• Presence of erythematous plaques or nodules on the skin.
• Symptoms may include pruritus or pain at the lesion site.
• Histological confirmation of CD30-positive T-cells in skin biopsies.
• Potential for systemic involvement if left untreated.

ICD-10 Code C86.60 for Primary cutaneous CD30-positive T-cell prolif not remission – SOAP Notes & Clinical Use

ICD-10 Code C86.60 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management.

What Does ICD-10 Code C86.60 for Primary cutaneous CD30-positive T-cell prolif not remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C86.60 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis. This code is essential for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C86.60 – Primary cutaneous CD30-positive T-cell prolif not remission

Management of Primary cutaneous CD30-positive T-cell proliferation not in remission may require hospitalization for intensive treatment. Therapeutic approaches focus on controlling the disease and alleviating symptoms.

Antibiotic Therapy:

• Not applicable as this condition is not infectious.

Supportive Care:

• Topical corticosteroids to reduce inflammation.
• Phototherapy for localized lesions.
• Systemic therapies such as methotrexate or brentuximab vedotin.

Infection Control:

• Standard precautions to prevent secondary infections.
• Monitoring for signs of infection in skin lesions.

How to Document Symptoms of Primary cutaneous CD30-positive T-cell prolif not remission (ICD-10 C86.60) in SOAP Notes

Subjective:

• Patient reports new skin lesions that are itchy and painful.
• History of previous skin lesions that have resolved.
• No known allergies to medications.
• Denies fever or systemic symptoms.

Objective:

• Erythematous plaques noted on examination.
• Skin biopsy reveals CD30-positive T-cells.
• Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
• No lymphadenopathy observed.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Primary cutaneous CD30-positive T-cell prolif not remission (ICD-10 Code C86.60)

Assessment:

• Primary cutaneous CD30-positive T-cell proliferation not in remission, moderate severity.
• ICD-10 Code: C86.60.
• Triggers may include previous skin lesions and potential environmental factors.

Plan:

• Initiate topical corticosteroids for inflammation.
• Consider referral for phototherapy.
• Educate patient on skin care and monitoring for new lesions.
• Schedule follow-up in 4 weeks to reassess.

Treatment & Plan Section for ICD-10 Code C86.60 – Primary cutaneous CD30-positive T-cell prolif not remission

• First-line treatment includes topical corticosteroids and phototherapy.
• Systemic therapies may be indicated for extensive disease.
• Patient education on skin care and monitoring for new lesions is essential.
• Regular follow-up appointments to assess treatment response and adjust therapy as needed.

Using ICD-10 Code C86.60 for Primary cutaneous CD30-positive T-cell prolif not remission in Billing & SOAP Note Compliance

• Ensure clear documentation of symptoms and clinical findings in SOAP notes.
• Use C86.60 when the condition is active and not in remission.
• Align treatment plans with clinical guidelines to support justified billing.
• Include relevant CPT codes that correspond to the services provided.

Related ICD-10 Codes Often Used with Primary cutaneous CD30-positive T-cell prolif not remission

• C84.90 – Peripheral T-cell lymphoma, unspecified
• C82.90 – Follicular lymphoma, unspecified
• C83.90 – Non-Hodgkin lymphoma, unspecified

ICD-10 Code C86.60 in Medical Billing and Insurance for Primary cutaneous CD30-positive T-cell prolif not remission

ICD-10 Code C86.60 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
• Use this code in conjunction with appropriate CPT codes for services rendered.
• Ensure that the diagnosis is clearly linked to the patient's symptoms and treatment in the medical record.

Common CPT Pairings: